Magnosco

Magnosco

Description

Magnosco is using Dermatofluoroscopy to detect melanoma. We developed DermaFC as digital second opinion for diagnostic support for dermatologists. The Medical device is supporting (early) diagnosis of malignant melanoma. It allows non-invasive and painless examination of atypical and dysplastic skin lesions using laser technology and AI. Furthermore, we developed a prototype for histological examinations and are currently working on a patient centered software regarding melanoma prevention.

Details

Headquarters: Berlin
Country: Germany
Founded: 2014
Employees: 4-10

Company presentation